Patents by Inventor Anthony George PHILLIPS

Anthony George PHILLIPS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TETRAHYDROPROTOBERBINE COMPOUNDS AND USES THEREOF IN THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND NEURODEGENERATIVE DISEASES
    Publication number: 20170100389
    Abstract: Tetrahydroprotoberbine (THPB) compounds and their use in the treatment of neurological, psychiatric and neurodegenerative diseases is provided. The compounds include d-govadine, l-govadine and racemic govadine, as well as d-THPBs of general formula (I). Enantioselective processes for preparing compounds of formula (I), and d- and l-govadine are also provided.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 13, 2017
    Inventors: James Jackson Miller, Anthony George Phillips, Christopher Court Lapish, Glenn Martin Sammis
  • Tetrahydroprotoberbine compounds and uses thereof in the treatment of neurological, psychiatric and neurodegenerative diseases
    Patent number: 9526721
    Abstract: Tetrahydroprotoberbine (THPB) compounds and their use in the treatment of neurological, psychiatric and neurodegenerative diseases is provided. The compounds include d-govadine, l-govadine and racemic govadine, as well as d-THPBs of general formula (I). Enantioselective processes for preparing compounds of formula (I), and d- and l-govadine are also provided.
    Type: Grant
    Filed: August 2, 2012
    Date of Patent: December 27, 2016
    Inventors: James Jackson Miller, Anthony George Phillips, Christopher Court Lapish, Glenn Martin Sammis
  • TETRAHYDROPROTOBERBINE COMPOUNDS AND USES THEREOF IN THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND NEURODEGENERATIVE DISEASES
    Publication number: 20150306092
    Abstract: Tetrahydroprotoberbine (THPB) compounds and their use in the treatment of neurological, psychiatric and neurodegenerative diseases is provided. The compounds include d-govadine, l-govadine and racemic govadine, as well as d-THPBs of general formula (I). Enantioselective processes for preparing compounds of formula (I), and d- and l-govadine are also provided.
    Type: Application
    Filed: August 2, 2012
    Publication date: October 29, 2015
    Inventors: James Jackson MILLER, Anthony George PHILLIPS, Christopher Court LAPISH, Glenn Martin SAMMIS